Bellvitge University Hospital — Clinical Trial Site

335 Registered trials

116 Currently recruiting

Organisation

Bellvitge University Hospital

Location

L'Hospitalet De Llobregat, Spain

Identifier

ORG-100028921

Address

Carretera De La Feixa Llarga S/n, Poligono Industrial De La Zona Ranca De Barcelona, 08908, Spain

Departments

-
#2103:Urología
#2305:servicio de neurología
#3014: Gastroenterology
#3279: Urologia
#3401:Reumatología
#3808:UCI/medicina intensiva
#40157; Neurologia
#40157: Neurologia
#4201:Servicio de Cardiología
#5417 :neurologia
#7004:Dermatología
#80: Neumología
#8001:Medicina Intensiva
1401: Reumatología
1503: Oncology
2451: Reumatología
2453:Oncologia
2602:Urology
3112: medicina interna
3505: Dermatología
4201: Lipidólogos (Medicina Interna)
5506: Neumología
7009: Anestesia
7219: Neurology
724004: Oftalmología
72403: Oftalmología
7511 Rheumatology
A25:Neurologia
Alergology
Allergollogy
allergology
Allergology Department
Allergyc
Anaesthesiology
anestesiology
Anesthesiology
Anesthesiology and Pain Department
Cardiología
Cardiology
Cardiology Department
Clinical Microbiology Department
Dementia Unit
Departamento de Anestesiología y Reanimación
Departamento de Neurología
department of Neurophisyiology
Department of Ophthalmology
Department of Psychiatry
Dermatología
Dermatology
Dermatology Department
Digestivo
Endocrinología
Endocrinology
Endocrinology and nutrition
Enfermedades Infecciosas
ESP1: Oftalmología
Gastroenterology
General and Digestive Surgery
General Medicine and Surgery
Gynecology department
Head of Psychiatry department
Hematologia Clinica
Hematology
Hepatology and Liver Transplant Unit Section. Digestive System
HIV and STD Unit (Infectious Disease Service)
Hospital Universitari de Bellvitge
Hospital Universitari de Bellvitge / Nephrology Dpt
Hospital Universitari de Bellvitge( #1)
Infecciosas
Infections and Cancer Laboratory (INCALAB) chief
Infectious disease
Infectious Diseases
Infectious diseases service
Infectious Diseases Unit
Institut Catala de Neurocience aplicades
Intensive Care
Intensive Care Department
Intensive Care Unit
Intensive Medicine
Internal Medicine
Internal Medicine department
Interventional Cardiology
Lipids and Vascular Risk Unit
Medicina Interna
Medicina Interna - Unitat de Risc Vascular
Medicina Preventiva y Epidemiologia
Medicine Preventive
N/A
NA
Nefrologia
Nefrología/ Nephrology
Nefrology
Nephrologist
Nephrology
Nephrology and Transplant
Nephrology and Renal Transplant
Nephrology and Renal Transplantation
Nephrology and Trasplant
Nephrology Service
NEUMOLOGIA
Neumology
Neurología
Neurologist
Neurology
Neurology Service
Neuromuscular Diseases Unit
Oftalmologia
Oncologia
Oncology
Ophtalmology
Ophthalmology
Otorhinolaryngolog Service
Pain Management Unit Anaesthesiology Department
Pneumology
Pneumology Department
Pneumology service
Pneumonology
Pneumonology Service
Preventive medicine
Preventive Medicine and Epidemiology Service
Preventive Medicine Department
Psychiatry
Pulmonology
Respiratory
Retina
Rheumatology
Servicio de Alergia
Servicio de Angiología y Cirugía vascular
Servicio de Cardiología
Servicio de Digestivo
Servicio de Enfermedades Infecciosas
Servicio de Hematología
Servicio de Infecciosas
Servicio de Medicina Interna
Servicio de Medicina Preventiva y Epidemiología
Servicio de Neumologia
Servicio de Neurología
Servicio de Otorrinolaringología
Servicio de Reumatología
Servicio de Urologia
Servicio Enfermedades Infecciosas
Servicio Medicina Interna
Servicio oftalmologia
site 003_Preventive Medicine Department
Surgery
Surgery and Liver Transplant Unit
Tuberculosis Unit, Service of Infectious Diseases
UMICO
Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva.
Unidad de VIH y enfermedades de transmision sexua servicio de enfermedades infecciosas
Unitat de Lipids i Risc Vascular
Unitat de Risc Vascular
Unitat de VIH i Malalties de Transmissió Sexual
Urology
Vascular Surgery

Clinical trials at this site (335)

Search interface

A Phase 1/2 Study of the Safety and Tolerability of ICM VTx-002 in participants with ALS Pending

2025-522697-37-00 Amyotrophic Lateral Sclerosis 7
An extension study to investigate the long-term safety and tolerability of itepekimab in adult participants with inadequately controlled chr… Pending

2025-522983-33-00 Chronic rhinosinusitis with nasal polyps 5
STUDY TO FIND OUT WHETHER A SHORTER ANTIBIOTIC TREATMENT (7 DAYS) IS AS EFFECTIVE AND SAFE AS THE USUAL ONE (14 DAYS) IN PATIENTS WITH AN IN… Pending

2025-523120-53-00 Graft pyelonephritis in kidney transplant recipients 11
Clinical trial to evaluate the clinical and microbiological impact of methenamine hippurate as an alternative prophylaxis in recurrent urin… Pending

2025-523922-42-00 recurrent urine infections 6
Phase II/III randomized controlled open-label trial to evaluate the efficacy and safety of personalized tissue engineered veins in patients … Pending

2025-524103-69-00 Chronic Venous Insufficiency 10
Combined impact of cardiovascular polypill treatment and a specific nurse education program on adherence to therapy in patients with ACS: a … Pending

2025-524751-32-00 Acute coronary syndrome 6
Study evaluating the efficacy and safety of daridorexant in patients with major depressive disorder and insomnia. Pending

2025-524794-16-00 Patients with major depressive episode and moderate to 6
Albuminuria Reduction Trial and Investigation with Survodutide Treatment in CKD (ARTIST-CKD) Pending

2025-525068-13-00 Chronic Kidney Disease 4
AURA-IPF: A Randomized Phase 2 Study to evaluate the safety and efficacy of AP02 (nintedanib solution) in IPF Recruiting

2025-523431-19-00 Idiopathic Pulmonary Fibrosis (IPF) 4 2026-05-20
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS (PREVAiLS) Recruiting

2025-524002-16-00 Amyotrophic Lateral Sclerosis 5 2026-05-12
An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
Darovasertib before Surgery or Radiation Therapy to Treat Early-stage Eye Cancer (Uveal Melanoma) Recruiting

2025-522387-32-00 Uveal Melanoma 5 2026-04-10
A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE) Recruiting

2025-521792-31-01 Homozygous Familial Hypercholesterolemia (HoFH) 5 2026-04-07
A study to investigate the efficacy and safety of frexalimab versus tacrolimus in adults undergoing kidney transplantation Recruiting

2025-521521-33-00 Kidney transplant rejection 10 2026-04-02
VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA) Recruiting

2024-512436-29-00 CARDIOVASCULAR DISEASES 11 2026-03-27
A Long-term Study of Navenibart in Participants with Hereditary Angioedema Recruiting

2025-521142-22-00 Hereditary Angioedema 5 2026-03-27
A Study of DCC-3116 in Combination With Anticancer Therapies in Participants With Advanced Malignancies Recruiting

2024-516476-15-00 Advanced gastrointestinal stromal tumor (GIST) 9 2026-03-04
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder Recruiting

2025-523202-32-00 Major Depressive Disorder 5 2026-02-26
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy. Recruiting

2025-522553-19-00 Symptomatic genetic and familial dilated cardiomyopathy 10 2026-02-25
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel Group Study to Evaluate the Efficacy and Safety of Trepostini… Recruiting

2025-521558-40-00 Pulmonary Hypertension Associated with Interstitial Lun 5 2026-02-12
EASE SBS 5 (Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS) Recruiting

2024-512486-14-00 Short Bowel Syndrome 5 2026-01-22
STOP-HAE: A Phase 3 Study of ADX-324 in HAE Recruiting

2025-521352-38-00 Hereditary Angioedema 5 2026-01-16
CLEOPATTRA: A research study to look at the effects of treatment with a medicine called coramitug (NNC6019-0001) in people with heart failur… Recruiting

2024-518899-31-00 Variant or wild-type transthyretin (TTR) amyloid cardio 5 2025-12-19
Withdrawal of neurohormonal therapy in patients with non-ischemic cardiomyopathy, no late gadolinium enhancement, and negative genetic testi… Recruiting

2025-521780-12-00 Non-ischemic cardiomyopathy 11 2025-12-16